A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4745 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01)
Patent
CA 2559532
Topoisomerase I inhibitors preferably the camptothecin derivative gimatecan, are administered for the treatment of proliferative diseases according to a once every three day fixed dosing regimens. Furthermore, the invention provides the use of topoisomerase inhibitors to manufacture a medicament for the treatment of a proliferative disease which can be used in a fixed dose treatment regimen.
Selon l'invention, des inhibiteurs de la topoisomérase I sont administrés en vue de traiter des maladies à évolution chronique, selon des schémas posologiques fixes de prise une fois tous les trois jours. L'invention concerne l'utilisation d'inhibiteurs de la topoisomérase pour fabriquer un médicament pouvant être utilisé selon un schéma posologique fixe.
Schran Horst F.
Woo Margaret Ma
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Use of camptothecin derivates for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of camptothecin derivates for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of camptothecin derivates for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1842533